For a while it was beginning to look as if you couldn't patent a drug in India without being opposed tooth and nail by local companies or non-profits (with good reason in a number of cases). Some innovators complained of the Indian patent law being too pro-generics. Others said - and Apothecurry agrees - that parts of India's … Continue reading India’s patented diabetes drugs : proof of the pudding
